Work

Phase Ib study of mapatumumab in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) and chronic viral hepatitis.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.4_suppl.261

Authors: W. Sun, D. Nelson, S. R. Alberts, F. Poordad, S. Leong, U. R. Teitelbaum, L. Woods, N. Fox, B. H. O'Neil

Institutions: University of North Carolina at Chapel Hill, Cedars-Sinai Medical Center, Mayo Clinic, University of Florida, University of Colorado Cancer Center, Abramson Cancer Center, University of Pennsylvania

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2229291850

Cites:

Cited by: 20

Related to: 10